Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-18

FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) submitted by Gilead Sciences. The approval updates the product labeling/addition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vemlidy (tenofovir alafenamide)

Snippet

SUPPL AP for VEMLIDY (TENOFOVIR ALAFENAMIDE)